Ye, S.-Y.; Li, J.-Y.; Li, T.-H.; Song, Y.-X.; Sun, J.-X.; Chen, X.-W.; Zhao, J.-H.; Li, Y.; Wu, Z.-H.; Gao, P.;
et al. The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr. Oncol. 2022, 29, 6137-6153.
https://doi.org/10.3390/curroncol29090482
AMA Style
Ye S-Y, Li J-Y, Li T-H, Song Y-X, Sun J-X, Chen X-W, Zhao J-H, Li Y, Wu Z-H, Gao P,
et al. The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Oncology. 2022; 29(9):6137-6153.
https://doi.org/10.3390/curroncol29090482
Chicago/Turabian Style
Ye, Shi-Yu, Jia-Yi Li, Teng-Hui Li, Yong-Xi Song, Jing-Xu Sun, Xiao-Wan Chen, Jun-Hua Zhao, Yuan Li, Zhong-Hua Wu, Peng Gao,
and et al. 2022. "The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" Current Oncology 29, no. 9: 6137-6153.
https://doi.org/10.3390/curroncol29090482
APA Style
Ye, S. -Y., Li, J. -Y., Li, T. -H., Song, Y. -X., Sun, J. -X., Chen, X. -W., Zhao, J. -H., Li, Y., Wu, Z. -H., Gao, P., & Huang, X. -Z.
(2022). The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Oncology, 29(9), 6137-6153.
https://doi.org/10.3390/curroncol29090482